ESCRS - Vision loss after anti-VEGF likely to be endophthalmitis

Vision loss after anti-VEGF likely to be endophthalmitis

Vision loss after anti-VEGF likely to be endophthalmitis

A review of the published case series of endophthalmitis following intravitreal injection indicates that those presenting with visual acuity 20/200 or less more than 24 hours after the injection were very likely to have endophthalmitis, while those presenting with a similar loss of vision during the first 24 hours were more likely to be due to different causes. The study's investigators used a Pubmed search of the literature and retrieved 12 case series, which together with their own case series included a total of 133 patients. The researchers found that the records showed that among those cases where antibiotics were deemed unnecessary the mean time to presentation was one day, but in those who received antibiotics the mean time to presentation was three days, whether or not their biopsy was positive for bacterial pathogens.
• (Hoevenaars et al, Ophthalmologica 2012, DOI: 10.1159/000339584.) 

Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...